PA
Perceptive Advisors’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.26M | Sell |
447,507
-212,155
| -32% | -$2.97M | 0.23% | 61 |
|
|
2025
Q1 | $8.89M | Sell |
659,662
-826,846
| -56% | -$11.1M | 0.31% | 56 |
|
|
2024
Q4 | $28.5M | Sell |
1,486,508
-1,326,157
| -47% | -$25.4M | 0.79% | 34 |
|
|
2024
Q3 | $64M | Buy |
2,812,665
+1,180,837
| +72% | +$26.9M | 1.35% | 25 |
|
|
2024
Q2 | $21.2M | Sell |
1,631,828
-2,025,271
| -55% | -$26.3M | 0.51% | 54 |
|
|
2024
Q1 | $64M | Buy |
3,657,099
+1,926,887
| +111% | +$33.7M | 1.12% | 31 |
|
|
2023
Q4 | $37.7M | Buy |
1,730,212
+719,007
| +71% | +$15.7M | 0.84% | 35 |
|
|
2023
Q3 | $15.5M | Sell |
1,011,205
-765,181
| -43% | -$11.7M | 0.52% | 52 |
|
|
2023
Q2 | $42.3M | Buy |
1,776,386
+40,000
| +2% | +$952K | 1.22% | 24 |
|
|
2023
Q1 | $44.2M | Buy |
1,736,386
+515,811
| +42% | +$13.1M | 1.3% | 21 |
|
|
2022
Q4 | $35.7M | Hold |
1,220,575
| – | – | 1% | 28 |
|
|
2022
Q3 | $25M | Buy |
1,220,575
+248,743
| +26% | +$5.1M | 0.73% | 37 |
|
|
2022
Q2 | $11.2M | Sell |
971,832
-451,221
| -32% | -$5.22M | 0.35% | 56 |
|
|
2022
Q1 | $26.3M | Hold |
1,423,053
| – | – | 0.53% | 47 |
|
|
2021
Q4 | $28.1M | Buy |
1,423,053
+53
| +0% | +$1.05K | 0.43% | 54 |
|
|
2021
Q3 | $23.4M | Buy |
1,423,000
+628,494
| +79% | +$10.3M | 0.34% | 65 |
|
|
2021
Q2 | $14.5M | Buy |
+794,506
| New | +$14.5M | 0.19% | 97 |
|